Indaptus Therapeutics, Inc.
General ticker "INDP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $170.9M (TTM average)
Indaptus Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -24.2%.
Estimated limits based on current volatility of 4.8%: low 2.06$, high 2.26$
Factors to consider:
- Total employees count: 7 (0.0%) as of 2024
- Top business risk factors: Regulatory and compliance, Operational and conduct risks, Supply chain disruptions, Market competition, Cybersecurity threats
- Current price 83.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [12.65$, 44.55$]
- 2025-12-31 to 2026-12-31 estimated range: [7.95$, 28.32$]
Financial Metrics affecting the INDP estimates:
- Negative: with PPE of -15.2 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -5.33 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Positive: Investing cash flow per share per price, % of 0 > -0.66
Short-term INDP quotes
Long-term INDP plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $14.91MM | $16.38MM | $15.37MM |
| Operating Income | $-14.91MM | $-16.38MM | $-15.37MM |
| Non-Operating Income | $0.59MM | $0.96MM | $0.34MM |
| R&D Expense | $6.32MM | $7.62MM | $7.25MM |
| Income(Loss) | $-14.32MM | $-15.42MM | $-15.02MM |
| Profit(Loss)* | $-14.32MM | $-15.42MM | $-15.02MM |
| Stockholders Equity | $24.63MM | $12.08MM | $3.94MM |
| Assets | $28.06MM | $14.92MM | $7.34MM |
| Operating Cash Flow | $-13.08MM | $-13.41MM | $-12.32MM |
| Capital expenditure | $0.17MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-16.43MM | $17.14MM | $0.00MM |
| Financing Cash Flow | $0.00MM | $0.00MM | $4.75MM |
| Earnings Per Share** | $-1.73 | $-1.84 | $-1.61 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.